Cargando…
CDK4/6 Inhibitors in Pancreatobiliary Cancers: Opportunities and Challenges
SIMPLE SUMMARY: Pancreatobiliary cancers are a group of malignancies affecting the pancreas and biliary tract and are among the cancers with the lowest survival rate. Current first-line treatments only offer a modest increase in overall survival, and there is an urgent need to develop new therapeuti...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913743/ https://www.ncbi.nlm.nih.gov/pubmed/36765923 http://dx.doi.org/10.3390/cancers15030968 |